Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2008 Mar 28;28313:8654-63. doi: 10.1074/jbc.M708615200.
Show Gene links
Show Anatomy links
Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.
Truong DM
,
Kaler G
,
Khandelwal A
,
Swaan PW
,
Nigam SK
.
???displayArticle.abstract???
Long-term exposure to antivirals is associated with serious cellular toxicity to the kidney and other tissues. Organic anion transporters (OATs) are believed to mediate the cellular uptake, and hence cytotoxicity, of many antivirals. However, a systematic in vitro and ex vivo analysis of interactions between these compounds with various OAT isoforms has been lacking. To characterize substrate interactions with mOat1, mOat3, and mOat6, a fluorescence-based competition assay in Xenopus oocytes as well as wild-type and knock-out whole embryonic kidney (WEK) organ culture systems was developed using 6-carboxyfluorescein, 5-carboxyfluorescein, and fluorescein. Of nine common antiviral drugs assessed in oocytes, many manifested higher affinity for SLC22a6 (mOat1), originally identified as NKT (e.g. adefovir and cidofovir), two (ddC and ddI) manifested significantly higher affinity for mOat3, while mOat6 had comparatively low but measurable affinity for certain antivirals. A live organ staining approach combined with fluorescent uptake in WEK cultures allowed the visualization of OAT-mediated uptake ex vivo into developing proximal tubule-like structures, as well as quantification of substrate interactions of individual OAT isoforms. In general, antiviral specificity of SLC22a6 (Oat1) (in Oat3(-/-) WEK culture) and SLC22a8 (Oat3) (in Oat1(-/-) WEK culture) was consistent with the Xenopus oocyte data. The combined observations suggest SLC22a8 (Oat3) is the major transporter interacting with ddC and ddI. Finally, quantitative structure-activity relationship analysis of the nine antivirals' physicochemical descriptors with their OAT affinity indicates that antiviral preferences of mOat1 are explained by high polar surface areas (e.g. phosphate groups), whereas mOat3 prefers hydrogen bond acceptors (e.g. amines, ketones) and low rotatable bond numbers. In contrast, hydrogen bond donors (e.g. amides, alcohols) diminish binding to mOat6. This suggests that, despite sharing close overall sequence homology, Oat1, Oat3, and Oat6 have signficantly different binding pockets. Taken together, the data provide a basis for understanding potential drug interactions in combination antiviral therapy, as well as suggesting structural mdifications for drug design, especially in the context of targeting toward or away from specific tissues.
Anderson,
The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities.
2004, Pubmed
Anderson,
The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities.
2004,
Pubmed
Antonelli,
2',3'-Dideoxycytidine cytotoxicity in human macrophages.
1997,
Pubmed
Anzai,
Integrated physiology of proximal tubular organic anion transport.
2005,
Pubmed
Bednarczyk,
NBD-TMA: a novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubules.
2000,
Pubmed
Bongiovanni,
Tenofovir plus didanosine as Nrti backbone in HIV-infected subjects.
2006,
Pubmed
Bonventre,
Mediators of ischemic renal injury.
1988,
Pubmed
Brady,
A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse.
1999,
Pubmed
Burckhardt,
Transport of organic anions across the basolateral membrane of proximal tubule cells.
2003,
Pubmed
Cha,
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.
2001,
Pubmed
,
Xenbase
Cha,
Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta.
2000,
Pubmed
,
Xenbase
Cihlar,
The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1.
1999,
Pubmed
,
Xenbase
Cihlar,
Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1.
2000,
Pubmed
Cihlar,
Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.
2001,
Pubmed
De Clerck,
Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function.
1994,
Pubmed
De Clercq,
Antiviral drugs in current clinical use.
2004,
Pubmed
Dresser,
Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters.
2001,
Pubmed
Epstein,
Physiology of renal hypoxia.
1994,
Pubmed
Epstein,
Oxygen and renal metabolism.
1997,
Pubmed
Eraly,
Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.
2006,
Pubmed
,
Xenbase
Eraly,
Novel aspects of renal organic anion transporters.
2003,
Pubmed
Eraly,
The molecular pharmacology of organic anion transporters: from DNA to FDA?
2004,
Pubmed
Hitchcock,
In vitro antiviral activity of didanosine compared with that of other dideoxynucleoside analogs against laboratory strains and clinical isolates of human immunodeficiency virus.
1993,
Pubmed
Jacqz-Aigrain,
Effects of drugs on the fetus.
2005,
Pubmed
Kaler,
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
2007,
Pubmed
Kaler,
Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anions.
2006,
Pubmed
Kojima,
Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney.
2002,
Pubmed
Laitinen,
Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates.
1987,
Pubmed
Lewis,
Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy.
2003,
Pubmed
Ljubojevic,
Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition.
2004,
Pubmed
Lopez-Nieto,
Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney.
1997,
Pubmed
,
Xenbase
Miller,
Confocal imaging of xenobiotic transport across the choroid plexus.
2004,
Pubmed
Monte,
Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa.
2004,
Pubmed
Pacifici,
Transfer of antivirals across the human placenta.
2005,
Pubmed
Pietruck,
Digital fluorescence imaging of organic cation transport in freshly isolated rat proximal tubules.
2006,
Pubmed
Ross,
Glucose metabolism in renal tubular function.
1986,
Pubmed
Sweet,
Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice.
2002,
Pubmed
,
Xenbase
Sweet,
Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney.
1997,
Pubmed
,
Xenbase
Sweet,
Organic anion transporter (Slc22a) family members as mediators of toxicity.
2005,
Pubmed
Sweet,
Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models.
2006,
Pubmed
Takeda,
Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.
2002,
Pubmed
Twentyman,
A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
1994,
Pubmed
Uwai,
Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
2007,
Pubmed
Vidal,
In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells.
2006,
Pubmed
Wada,
Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs.
2000,
Pubmed
,
Xenbase
Young,
Review: mixing new cocktails: drug interactions in antiretroviral regimens.
2005,
Pubmed
Zubercová,
The multidrug resistance in human leukemias. Minireview.
1998,
Pubmed
